Calendar

Week of Mar 4, 2024

Mar 6, 2024approval889d agoLIBTAYO (CEMIPLIMAB-RWLC) — FDA approvalcemiplimab

Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INTRAVENOUS

Mar 6, 2024approval889d agoLETROZOLE — FDA approvalHikma Pharmaceuticals Plc

Sponsor: HIKMA PHARMS. Form: TABLET. Route: ORAL

Mar 6, 2024approval889d agoVARENICLINE TARTRATE — FDA approvalMylan Pharmaceuticals Inc

Sponsor: NE RX PHARMA. Form: TABLET. Route: ORAL

Mar 7, 2024approval888d agoCAPRELSA (VANDETANIB) — FDA approvalvandetanib

Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL

Mar 7, 2024approval888d agoROXICET (ACETAMINOPHEN) — FDA approvalacetaminophen ER

Sponsor: HIKMA. Form: TABLET. Route: ORAL

Mar 8, 2024approval887d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

Mar 8, 2024approval887d agoCEFAZOLIN SODIUM — FDA approvalSamson Medical Technologies LLC

Sponsor: HQ SPCLT PHARMA. Form: POWDER. Route: INTRAVENOUS

Mar 8, 2024approval887d agoMETHADONE HYDROCHLORIDE — FDA approvalMETHADONE HYDROCHLORIDE

Sponsor: THEPHARMANETWORK LLC. Form: TABLET. Route: ORAL

Mar 8, 2024approval887d agoMETHADONE HYDROCHLORIDE — FDA approvalMETHADONE HYDROCHLORIDE

Sponsor: THEPHARMANETWORK LLC. Form: TABLET. Route: ORAL

Mar 8, 2024approval887d agoPRALUENT (ALIROCUMAB) — FDA approvalalirocumab

Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION

Mar 8, 2024approval887d agoESCITALOPRAM OXALATE — FDA approvalAbbVie Inc.

Sponsor: SUN PHARMA CANADA. Form: SOLUTION. Route: ORAL

Mar 11, 2024approval884d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

Mar 11, 2024approval

page 4 of 479